https://www.selleckchem.com/pr....oducts/halofuginone.
The majority of those contacted attended a follow-up appointment within the 9-month project (77%, n=181) and achieved an improved systolic blood pressure (87%, n=167) and diastolic blood pressure (76%, n=146). Target blood pressure of 140/90 mmHg was achieved in 29% of patients (n=53). Medication possession ratio improved from 23% to 40% among patients reached by pharmacists (n=3. Fewer deaths occurred in those reached by the intervention than in those not reached (n=1 vs n=3). Multidisciplinary outreach and use of evidence-b
Curtir
Comentario
Compartilhar
